# Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adalimumab-etanercept-infliximab-certolizumab-pegol-golimumab-tocilizumab-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matt Stevenson,Rachel Archer,Jonathan Tosh,Emma Simpson,Emma Everson-Hock,John Stevens,Mónica Hernández Alava,Suzy Paisley,Kath Dickinson,David L. Scott,Adam Young,Allan Wailoo |
| Citations | 165 |
| DOI | 10.3310/hta20350 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://njl-admin.nihr.ac.uk/document/download/2003416 |
| OpenAlex ID | https://openalex.org/W2347164991 |
| PMID | 27140438 |
| Type | review |
| Year | 2016 |

## Paper authors

- [John Stevens](https://scholariq.org/researchers/john-stevens/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.